Training experts in antigen processing to deliver new drug prototypes for cancer and autoimmune diseases

Project Information

CAPSTONE

Grant agreement ID: 954992

DOI 10.3030/954992

EC signature date 3 September 2020

Start date 1 January 2021

End date 31 December 2024

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 3 968 730,62

EU contribution € 3 968 730,62

Coordinated by

UNIVERSITE DE LILLE
France

Deliverables

Websites, patent fillings, videos etc. (1)

ETN CAPSTONE website

Publications

Peer reviewed articles (1)

ERAP Inhibitors in Autoimmunity and Immuno-Oncology: Medicinal Chemistry Insights

Author(s): Vasileios Fougiaxis, Ben He, Tuhina Khan, Rodolphe Vatinel, Nikoletta M. Koutroumpa, Antreas Afantitis, Laetitia Lesire, Pierre Sierocki, Benoit Deprez, Rebecca Deprez-Poulain
Published in: Journal of Medicinal Chemistry, Issue 67, 2024, Page(s) 11597-11621, ISSN 0022-2623
Publisher: American Chemical Society
DOI: 10.1021/acs.jmedchem.4c00840